OTHERClinicalTrials.govClinical trialNewly listed
A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).
Phase 1Not yet recruitingJul 31, 2026
What changed
Change Tracker
A factual log of movement in the official registries: records that were newly listed, revised, or closed to enrolment within the selected window. Status labels are taken directly from the registry.
119 changes since 2026-07-25
Trial records retrieved live from the ClinicalTrials.gov public API.
Newly listed
Records first posted within this window
OTHERClinicalTrials.govClinical trialNewly listed
Analgesic Efficacy of Combined PECS II and PIP Block Versus Thoracic Paravertebral Block Post-Mastectomy
Not applicableRecruitingJul 31, 2026
EUClinicalTrials.govClinical trialNewly listed
Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
RecruitingJul 31, 2026
CNClinicalTrials.govClinical trialNewly listed
Clinical Research Cohort for Polycystic Ovary Syndrome
Active, not recruitingJul 31, 2026
CNClinicalTrials.govClinical trialNewly listed
Development and Clinical Application of ApoC3 Protein as a Predictive Biomarker for Insulin Resistance in Polycystic Ovary Syndrome
Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialNewly listed
EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer
Not applicableNot yet recruitingJul 31, 2026
USClinicalTrials.govClinical trialNewly listed
IKS04 Regimen in Advanced Solid Tumors That Express CA242
Phase 1Not yet recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trialNewly listed
Long Term Cohort Study of Adding Ovarian Function Suppression to Tamoxifen in Young Women
Not yet recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trialNewly listed
Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study
Phase 1/2Not yet recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trialNewly listed
Remimazolam for Postoperative Sleep in Elderly Patients
Not applicableNot yet recruitingJul 31, 2026
EUClinicalTrials.govClinical trialNewly listed
Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Phase 2Not yet recruitingJul 31, 2026
Recently updated
Existing records whose official page was revised
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Phase 1/2RecruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
Phase 3Active, not recruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Phase 3RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Phase 1RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
Phase 2Active, not recruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trialRecord updated
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Phase 3RecruitingJul 31, 2026
OTHERClinicalTrials.govClinical trialRecord updated
A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.
Not yet recruitingJul 31, 2026
EUCNOTHERClinicalTrials.govClinical trialRecord updated
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Phase 1Enrolling by invitationJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Not applicableRecruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer
Phase 1/2Active, not recruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Phase 3Active, not recruitingJul 31, 2026
EUOTHERClinicalTrials.govClinical trialRecord updated
A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting
RecruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trialRecord updated
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
Phase 2Active, not recruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Phase 1RecruitingJul 31, 2026
EUCNOTHERClinicalTrials.govClinical trialRecord updated
A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Phase 1Active, not recruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trialRecord updated
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
Phase 1Active, not recruitingJul 31, 2026
EUCNOTHERClinicalTrials.govClinical trialRecord updated
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
Phase 2RecruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
Phase 3Active, not recruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Phase 3Active, not recruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Phase 3RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Phase 2/3RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Phase 2RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Phase 1RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Breast Cancer, Reasoning, and Activity Intervention
Not applicableRecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 1Active, not recruitingJul 31, 2026
EUClinicalTrials.govClinical trialRecord updated
Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)
Not applicableRecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Phase 3Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.
Phase 1Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
Phase 2RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device
Not applicableActive, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma
availableJul 31, 2026
EUClinicalTrials.govClinical trialRecord updated
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours
Phase 1RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Getting To Implementation: Improving Cancer Screening for Veterans
Not applicableEnrolling by invitationJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Phase 1Not yet recruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trialRecord updated
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Phase 3Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
Phase 1RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Not applicableRecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Enrolling by invitationJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
RecruitingJul 31, 2026
OTHERClinicalTrials.govClinical trialRecord updated
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
Phase 2RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Phase 3Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Phase 3Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Obeticholic Acid for Prevention in Barrett's Esophagus
Phase 2RecruitingJul 31, 2026
EUClinicalTrials.govClinical trialRecord updated
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
Phase 3RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
Phase 2Active, not recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trialRecord updated
Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)
Phase 3RecruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Phase 2Active, not recruitingJul 31, 2026
EUClinicalTrials.govClinical trialRecord updated
Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)
Not applicableActive, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs
Phase 2Active, not recruitingJul 31, 2026
EUClinicalTrials.govClinical trialRecord updated
Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy
Phase 3Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
Phase 1Not yet recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
Phase 2Not yet recruitingJul 31, 2026
EUOTHERClinicalTrials.govClinical trialRecord updated
Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
Phase 3RecruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
Study for AZD4360 in Participants With Advanced Solid Tumours
Phase 1/2Active, not recruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trialRecord updated
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 3RecruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trialRecord updated
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Phase 3Active, not recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trialRecord updated
Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
Phase 2Active, not recruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Phase 1/2RecruitingJul 31, 2026
CNClinicalTrials.govClinical trialRecord updated
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy
Phase 3RecruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trialRecord updated
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Phase 3Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
Phase 1Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Phase 2RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Phase 1/2RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
Phase 1RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers
Phase 1Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
Phase 1Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer
Phase 1Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors
Phase 1Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Phase 1/2RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
Phase 2RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
Phase 3Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Phase 1/2RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery
Phase 2RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer
Phase 2Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Phase 2RecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Phase 1RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
Phase 3Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 3Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trialRecord updated
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
Phase 2Active, not recruitingJul 31, 2026
USEUClinicalTrials.govClinical trialRecord updated
TheraSphere With Durvalumab and Tremelimumab for HCC
Phase 2Active, not recruitingJul 31, 2026
CNClinicalTrials.govClinical trialRecord updated
TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria
Not applicableRecruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer
Phase 1/2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trialRecord updated
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Phase 1Active, not recruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
Phase 1/2RecruitingJul 30, 2026
USClinicalTrials.govClinical trialRecord updated
Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer
Phase 2Active, not recruitingJul 30, 2026
USCNOTHERClinicalTrials.govClinical trialRecord updated
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
Phase 1Active, not recruitingJul 30, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
Phase 1/2Active, not recruitingJul 30, 2026
USEUCNOTHERClinicalTrials.govClinical trialRecord updated
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Phase 2/3RecruitingJul 30, 2026
USClinicalTrials.govClinical trialRecord updated
Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)
Phase 2Active, not recruitingJul 30, 2026
No longer open
Records whose status indicates enrolment has ended
EUClinicalTrials.govClinical trialNo longer open
A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide
CompletedJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trialNo longer open
A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer
Phase 1/2CompletedJul 31, 2026
USOTHERClinicalTrials.govClinical trialNo longer open
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
Phase 3CompletedJul 31, 2026
USClinicalTrials.govClinical trialNo longer open
Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer
Phase 1SuspendedJul 31, 2026
USClinicalTrials.govClinical trialNo longer open
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors
Phase 1SuspendedJul 31, 2026
USClinicalTrials.govClinical trialNo longer open
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
Phase 2CompletedJul 30, 2026
This site does not provide medical advice
TrialBeacon only aggregates links to publicly available official information. It does not recommend, rank or evaluate any treatment, trial or medicine, and nothing here implies suitability for any individual. Please discuss anything you find with your treating doctor, and always rely on the original official page — records change over time. Full disclaimer.